Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)

Williams, Kerry, Lada, Georgia, Reynolds, Nick J., Mcelhone, Kathleen, Evans, Ian, Warren, Richard B., Walton, Shernaz, Hughes, Olivia, Bewley, Anthony, Mason, Kayleigh and Kleyn, C. Elise 2025. Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR). Clinical and Experimental Dermatology 50 (4) , pp. 804-811. 10.1093/ced/llae449

[thumbnail of llae449.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (680kB) | Preview

Abstract

Background Psoriasis is associated with poor mental health and reduced quality of life. Although the high risk for depression in patients with psoriasis is well-established, their suicidality risk is uncertain. Previous studies provide contrasting results and have not included patients with clinically-confirmed severe disease. Objectives Our aim was to determine risk of suicide among patients with moderate to severe psoriasis compared with the general population, and investigate if psychiatric comorbidity or history of suicidality increases future suicidality risk in psoriasis. We further estimated the incidence of suicidal and self-injurious behaviours in patients. Methods Analysis was performed using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). As controls, general population mortality and suicide data were used. Results There were 9 suicides in BADBIR. The incidence rate of suicide was 12.5 per 100,000 person-years (95% CI 6.53, 24.11) in BADBIR versus 11.0 per 100,000 person-years (95% CI 10.7, 11.3) in the general population in England and Wales. Among patients, psychiatric comorbidity or past suicidality was associated with higher risk for suicidal ideation, suicide attempts and self-injurious behaviours. Conclusions Suicide rates among patients with moderate to severe psoriasis were not significantly higher compared with the general population. Suicide is a rare event and our results are limited by the uncertainty in the estimate reliability. However, considering the high depression prevalence in psoriasis, our findings support the need for prompt assessment of patients for psychiatric comorbidities and suicidality history. Further research is required on suicidal behaviours and the role of psoriasis severity.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Psychology
Publisher: Oxford University Press
ISSN: 0307-6938
Funders: UKRI/Wellcome
Date of First Compliant Deposit: 25 October 2024
Date of Acceptance: 18 October 2024
Last Modified: 16 Apr 2025 12:45
URI: https://orca.cardiff.ac.uk/id/eprint/173405

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics